Women & Gender

{Photo credit: Warren Zelman}Photo credit: Warren Zelman

In 2012, the United Nations unanimously passed a resolution endorsing the concept of universal health coverage (UHC), urging governments everywhere to “provide all people with access to affordable, quality health care services”. Management Sciences for Health (MSH) and the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program are among global champions for UHC and joined global leaders celebrating UHC’s notable inclusion in the Sustainable Development Goals (SDGs) last Fall. Now, we continue to help countries face the obstacles of making UHC a reality.

Access to medicines has not always been at the forefront of the global discourse on UHC, which instead has tended to focus on financing. UHC programs must include adequate health financing and coverage of essential medicines if they are to deliver meaningful health outcomes. Policymakers attempting to establish and maintain UHC programs therefore need to have a sound understanding of the pharmaceutical sector and those pharmaceutical system components that must be considered to ensure ready access to the pharmaceuticals needed to support any UHC program.

{Photo Credit: Rui Pires}Photo Credit: Rui Pires

At an event discussing maternal, newborn, and child survival, MSH’s country representative from Nigeria called for more attention on gestational diabetes (GDM) in her country.

The January 19 summit in Washington, DC, titled “Reaching the Last 25 Percent: Saving the Lives of Women and Newborns Through a Life Cycle Approach,” was convened by MSH, Novo Nordisk, and the NCD Roundtable. The meeting’s keynote address and two panel discussions focused on how governments, civil society, and the private sector in low- and middle-income countries are addressing maternal mortality and morbidity from non-communicable diseases (NCDs).

During a panel titled “Examples of NCD Integration in Maternal Health,” MSH Nigeria Country Representative Dr. Zipporah Kpamor discussed a recent pilot program that uses mobile health technology to measure blood glucose levels in pregnant women with GDM. The program aimed to provide women with faster, more convenient, and confidential blood glucose monitoring and a way to limit appointments, and reduce waiting time and transportation costs. The program was funded by MSH’s Internal Innovations Challenge (INCH) fund.

 {Photo credit: Brigid Boettler/MSH}Expert panelists discuss MDR-TB (from left): Joshua Michaud, Kaiser Family Foundation; Alexander Golubkov, USAID; Muluken Melese, MSH, Ethiopia; and Kenneth Mutesasira, MSH, Uganda.Photo credit: Brigid Boettler/MSH

“When we started our project in 2011, there was no system in place to identify multidrug-resistant tuberculosis (MDR-TB),” explained Muluken Melese, project director for the Help Ethiopia Address the Low Tuberculosis Performance (HEAL TB) project. However, since then, the five-year USAID-funded project, implemented by Management Sciences for Health (MSH), has expanded access to TB services to over half the population of Ethiopia and led a 15-fold increase in the number of MDR-TB patients on treatment.

 {Photo credit: Matt Martin/MSH}About 20 of the nearly 30 MSH staff attending the 4th annual ICFP gather for the opening ceremony.Photo credit: Matt Martin/MSH

Three weeks ago, nearly 3,500 family planning researchers, program managers, and policymakers came together in Nusa Dua, Indonesia to discuss the latest research findings and best practices on family planning at the 4th International Conference on Family Planning (ICFP). It was the largest gathering of family planning enthusiasts to date.

Nearly 30 MSH staff from 8 countries attended ICFP, showcasing our health systems expertise and experiences in family planning.

 {Photo: Sarah McKee/MSH}Youth delegates close out the 4th ICFP in song on January 28, 2016.Photo: Sarah McKee/MSH

A version of this post originally appeared on USAID's Leadership, Management & Governance (LMG) project blog. Nearly 30 staff from Management Sciences for Health (MSH), including several from LMG, participated in the fourth International Conference on Family Planning (ICFP), January 25-28, 2016, in Nusa Dua, Indonesia, which called for "Global Commitments, Local Actions.” The conference was co-hosted by the Bill and Melinda Gates Institute for Population and Reproductive Health at Johns Hopkins Bloomberg School of Public Health and the National Population and Family Planning Board of Indonesia (BKKBN).

 {Photo: Matt Martin/MSH}(from left) Jonathan D. Quick, President & CEO, MSH, moderates the UHC and family planning (FP) access and accountability conversation with panelists: Chris Baryomunsi, Minister of Health, Uganda; Tira Aswitama, National Program Associate for RH and FP, UNFPA Indonesia; Kayode Afolabi, Director Reproductive Health, Federal Ministry of Health, Nigeria; Beth Schlachter, Executive Director, FP2020; John Skibiak, Director, RHSC; Melissa Wanda, Advocacy Officer, MSH Kenya.Photo: Matt Martin/MSH

Post updated February 19, 2016.

Universal Health Coverage (UHC) and universal access to sexual and reproductive health services figure prominently in the Sustainable Development Goals. So it is not surprising that The International Conference on Family Planning (ICFP) maintained important focus on these topics, including through the Management Sciences for Health (MSH) auxiliary event, “Universal Access to Family Planning and Reproductive Health: Who’s Accountable in the Post-2015 Era?” on January 27. Co-sponsored by the Reproductive Health Supplies Coalition (RHSC) and Family Planning 2020 (FP2020), the event featured an illustrious group of panelists giving their perspectives on UHC, while exploring the intersection of health financing policy and accountability as countries move into universal access for family planning.

Jonathan D. Quick, MD, MPH, President and CEO of MSH, moderated the conversation and perhaps stated it best: “Now, more than ever, it is clear that getting family planning into national policies is critical.” 

{Photo: Gwenn Dubourthournieu}Photo: Gwenn Dubourthournieu

For the fourth year in a row, Management Sciences for Health (MSH) invited staff to submit stories about how health systems save lives and improve the health of the poorest and most vulnerable worldwide. MSH staff from 34 projects submitted over 50 stories from 2015. These 12 stories, selected by MSH staff judges, demonstrate how good storytelling and effective partnerships can save more lives.

In this special edition of our Global Health Impact Newsletter (subscribe), meet health workers, community leaders, pharmacy managers, beneficiaries working together toward healthier communities. Stories and authors appear alphabetically by country:

An Accredited Medicines Stores (AMS) seller receives an infrared thermometer to use in Ebola and other outbreak surveillance.

by Arthur Loryoun

Editor's note: This post originally appeared on the Bill & Melinda Gates Foundation's blog, Impatient Optimists. Funded by the Gates Foundation and led by Management Sciences for Health (MSH), the Sustainable Drug Sellers Initiative (SDSI) project worked to ensure the sustainability of public-private drug seller initiatives in Tanzania and Uganda, and to roll-out the initiative in Liberia.

MSH's Douglas Keene, PharmD, MHS, Vice President, Pharmaceuticals & Health Technologies Group, was among the speakers at a recent event in Basel, Switzerland, hosted by Novartis, with representatives from NGOs, academia, and government discussing how to expand access to health in developing countries, including through the newly-launched program, Novartis Access.

MSH is partnering on Novartis Access to help empower governments of low- and lower-middle-income countries to provide access to health for chronic diseases patients who need it most. Ensuring affordable and equitable access to medicines is critical to achieving health for all -- and central to MSH's mission and health-systems strengthening approach.

{Photo Credit: Sara Holtz/MSH}Photo Credit: Sara Holtz/MSH

As the world begins working toward the newly developed Sustainable Development Goals (SDGs), ensuring access to reproductive health supplies must be considered.

More than 100 countries are in the process of adopting or advancing universal health coverage (UHC) mechanisms to achieve the targets set for Goal 3, which calls for “good health and well-being.”

Despite the momentum, 400 million people lack access to at least one of seven life-saving health services. And in 2012, an estimated 222 million women lacked access to effective family planning. FP2020’s goal of enabling 120 million women and girls to use modern contraception requires countries to include sexual and reproductive health services and supplies when discussing health benefits packages under national insurance laws, policies, and other related UHC efforts. Moreover, marginalized populations should be prioritized for free or subsidized care.

Pages

Subscribe to RSS - Women & Gender